-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Maravai Lifesciences Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
- Maravai Lifesciences Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$169M, a 997% decline year-over-year.
- Maravai Lifesciences Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$205M, a 341% decline year-over-year.
- Maravai Lifesciences Holdings, Inc. annual Operating Income (Loss) for 2023 was -$31.6M, a 106% decline from 2022.
- Maravai Lifesciences Holdings, Inc. annual Operating Income (Loss) for 2022 was $574M, a 3.53% increase from 2021.
- Maravai Lifesciences Holdings, Inc. annual Operating Income (Loss) for 2021 was $555M, a 363% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)